179 related articles for article (PubMed ID: 16042064)
1. [The role of polyclonal anti-T-lymphocyte antibodies (ATG) in the kidney transplantation].
Nikolovski M; Kotsev Iu; Dimitrov S; Nikolova M; Panchev P
Khirurgiia (Sofiia); 2004; 60(4-5):42-5. PubMed ID: 16042064
[TBL] [Abstract][Full Text] [Related]
2. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
3. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
4. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
Mariat C; Alamartine E; Diab N; de Filippis JP; Laurent B; Berthoux F
Transpl Int; 1998; 11(3):231-6. PubMed ID: 9638854
[TBL] [Abstract][Full Text] [Related]
5. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
[TBL] [Abstract][Full Text] [Related]
6. The influence of the immunosuppressants OKT3 and ATG on immunological parameters.
Neumann MC; Müller TF; Sprenger H; Gemsa D; Lange H
Clin Nephrol; 1996 May; 45(5):345-8. PubMed ID: 8738669
[TBL] [Abstract][Full Text] [Related]
7. Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.
van den Hoogen MW; Hoitsma AJ; Hilbrands LB
Expert Opin Biol Ther; 2012 Aug; 12(8):1031-42. PubMed ID: 22583145
[TBL] [Abstract][Full Text] [Related]
8. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
Schulz T; Papapostolou G; Schenker P; Kapischke M
Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
[TBL] [Abstract][Full Text] [Related]
9. Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.
van de Linde P; Vd Boog PJ; Tysma OM; Elliott JF; Roelen DL; Claas FH; de Fijter JW; Roep BO
Clin Exp Immunol; 2007 Jul; 149(1):56-62. PubMed ID: 17459076
[TBL] [Abstract][Full Text] [Related]
10. Is there any role for antithymocyte induction in renal transplantation?
Neidlinger NA; Sollinger HW
Transplant Proc; 2010 Jun; 42(5):1402-7. PubMed ID: 20620444
[TBL] [Abstract][Full Text] [Related]
11. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
[TBL] [Abstract][Full Text] [Related]
12. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
13. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients.
Ravichandran P; Natrajan T; Jaganathan R
Int Immunopharmacol; 2006 Dec; 6(13-14):1973-6. PubMed ID: 17161350
[TBL] [Abstract][Full Text] [Related]
15. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
[TBL] [Abstract][Full Text] [Related]
16. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation.
Bock HA; Gallati H; Zürcher RM; Bachofen M; Mihatsch MJ; Landmann J; Thiel G
Transplantation; 1995 Mar; 59(6):830-40. PubMed ID: 7701577
[TBL] [Abstract][Full Text] [Related]
17. Perioperative single high dose ATG-Fresenius S administration as induction immunosuppressive therapy in cadaveric renal transplantation--preliminary results.
Samsel R; Chmura A; Włodarczyk Z; Wyzgał J; Cieciura T; Lagiewska B; Pliszczyński J; Korczak G; Lazowski T; Paczek L; Wałaszewski J; Lao M; Rowiński W
Ann Transplant; 1999; 4(2):37-9. PubMed ID: 10850589
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
[TBL] [Abstract][Full Text] [Related]
19. Pretransplantation GAD-autoantibody status to guide prophylactic antibody induction therapy in simultaneous pancreas and kidney transplantation.
Ringers J; van der Torren CR; van de Linde P; van der Boog PJ; Mallat MJ; Bonifacio E; Roep BO; de Fijter JW
Transplantation; 2013 Oct; 96(8):745-52. PubMed ID: 23912172
[TBL] [Abstract][Full Text] [Related]
20. [Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration].
Mourad G; Portales P; Garrigue V; Djamali A; Bouloux C; Chong G; Clot J
Nephrologie; 2000; 21(5):253-8. PubMed ID: 11068775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]